Virios Therapeutics to Present at the 34th Annual Roth Conference on Monday, March 14, 2022

Author's Avatar
Mar 08, 2022

Virios+Therapeutics%2C+Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat chronic diseases, including fibromyalgia, announced today that Greg Duncan, Chairman and Chief Executive Officer, will participate in a fireside chat at the 34th Annual Roth Conference on Monday, March 14, 2022 at 10:00 a.m. PT.